Navigation Links
Patent Granted for Simbionix Procedure Rehearsal Studio™
Date:8/10/2011

CLEVELAND, Ohio, August 10, 2011 /PRNewswire/ --

Simbionix USA Corporation, the world's leading provider of medical simulation training and education products for medical professionals and the healthcare industry, is pleased to announce it has been granted a patent in the UK for its innovative PROcedure Rehearsal Studio.

The PROcedure Rehearsal Studio™ is a first in industry product, allowing clinicians to create patient specific 3D and 4D anatomical models based on a patient's imaging data, such as CT, for the purpose of simulating and planning endovascular procedures. The patent was granted on Simbionix's proprietary technology used in order to simulate an image guided angioplasty procedure based on input from a patient's 3D medical image, allowing a hands-on planning and rehearsal experience as well as providing physicians with unlimited generation of unique clinical case studies and the ability to better demonstrate a complex clinical procedure to their patients.

Earlier this year, the PROcedure Rehearsal Studio software was market cleared in the United States, intended for use as a software interface and image segmentation system for the transfer of imaging data from a medical scanner to an output file. It is also intended as pre-operative software for simulating and evaluating surgical treatment options. Unique to the Simbionix simulation systems, the 3D segmentation model can be exported to the Simbionix ANGIO Mentor™ Simulator practice environment. The results are an advanced method of creating an ever expanding library of modules for training and post-operative debriefing.  

"This addition to the company's comprehensive IP portfolio is evidence to the uniqueness and quality of Simbionix's products and exceptional development team," said Simbionix CFO, Mr. Boaz Tal. "Technologically advanced medical education solutions are becoming more accepted and are regularly integrated into medical training programs. The patented PROcedure Rehearsal Studio allows for the integration of medical imaging into training, stregthening the link between the clinical and training. Having been granted the patent is an additional sign of recognition for the Simbionix comprehensive line of products, which provide innovative solutions to advance medical performance and ensure patient safety."

About Simbionix USA Corporation  

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit http://www.simbionix.com

Contact: Rebecca Zitter, +1-216-229-2040 - ext. 128, rebecca@simbionix.com



'/>"/>
SOURCE Simbionix USA Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Echo Therapeutics Announces Multiple Patents and Trademark Grants
2. Hepatitis B Vaccine - Comprehensive Patent Search
3. Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology
4. Mylan Announces U.S. PTO Intends to Reissue Two Perforomist® Patents to Dey Pharma
5. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
6. Watson Confirms JALYN™ Patent Challenge
7. BioMedix™ Receives Patent for Its Innovative Collaborative Care Business Method
8. Kuros Announces Allowance of US Patent for the Local Application of Parathyroid Hormone (PTH) for Bone Healing
9. Amgen Resolves G-CSF Patent Litigation With Teva
10. Convergen LifeSciences Announces Patent Award
11. Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Ischemic Stroke Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Ischemic Stroke Market and Competitive Landscape Highlights ... Stroke pipeline products, Acute Ischemic Stroke epidemiology, ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Actinic Keratosis ...  report to their offering.       ... Actinic Keratosis Market and Competitive Landscape Highlights ... pipeline products, Actinic Keratosis epidemiology, Actinic Keratosis ...
(Date:5/3/2016)... , May 4, 2016 ... 154 pages, profiling 09 key companies and supported ... professional and in-depth study on the current state ... overview of the industry including definitions, classifications, applications ... analysis is provided for the international market including ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... ... A new collaboration will give more researchers access to the largest and ... leader SAS will provide researchers worldwide with data management and analytics tools to explore ... , The DCRI and SAS share the goal of greater transparency and openness in ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star Insurance of Northeast ... the people of their local community. The agency pledges to select a new ... hope is to bring awareness to important local causes with fundraising and other ...
(Date:5/4/2016)... ... , ... May kicked off with Melanoma Monday , a multi-agency effort ... Turner is encouraging her patients, as well as residents all around Dallas, Cleburne, Irving, ... now and in the future. , The dermatology-specific awareness month ends with “Don’t Fry ...
(Date:5/4/2016)... ... May 04, 2016 , ... Dr. Elyson and Dr. Assili, dentist in ... office. Wisdom tooth removal, a common dental procedure, is performed for many adolescents and ... erupted, resulting in risks of complications. By providing wisdom tooth removal surgery at their ...
(Date:5/4/2016)... California (PRWEB) , ... May 04, 2016 , ... ... formulation of foundational nutrients that supports cellular and metabolic health. This synergistic combination ... 400 mg free-form curcumin, along with 150 mg of reduced glutathione and 200 ...
Breaking Medicine News(10 mins):